Navigation Links
The Advisory Board Company Schedules Third Quarter Investor Conference Call for February 5, 2008
Date:1/24/2008

WASHINGTON, Jan. 24 /PRNewswire-FirstCall/ -- The Advisory Board Company (Nasdaq: ABCO) announced today that it will hold an investor conference call hosted by Frank J. Williams, Chairman and Chief Executive Officer, and Michael T. Kirshbaum, Chief Financial Officer, to discuss the Company's financial results for the quarter ended December 31, 2007. The call will be held on Tuesday, February 5, 2008, at 6:00 p.m. Eastern Time. The Company plans to release its third quarter financial results after the market closes on Tuesday, February 5, 2008.

The ABCO investor conference call will be available via live web cast on the Company's web site at http://www.advisoryboardcompany.com in the section entitled "The Firm," found under the tab "Investor Relations." To participate by telephone, the dial-in number is 888.873.4896 and the access code is 20590693. Call participants are advised to dial in at least five minutes prior to the call to register. The web cast will be archived for seven days: from 8:00 p.m., Tuesday, February 5, 2008, until 8:00 p.m., Tuesday, February 12, 2008.

About The Advisory Board Company

The Advisory Board Company provides best practices research and analysis to the health care industry, focusing on business strategy, operations and general management issues. The Company provides best practices and research through discrete programs to a membership of more than 2,600 hospitals, health systems, pharmaceutical and biotech companies, health care insurers, and medical device companies in the United States. Each program typically charges a fixed annual fee and provides members with such services as best practice research reports, executive education, on-line analytical tools, and other supporting research services.


'/>"/>
SOURCE The Advisory Board Company
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Statement from the Consumer Healthcare Products Association on Todays FDA Advisory Committee Meeting on the Efficacy of Phenylephrine in the 10 Mg Oral Dose
2. American Society for Aesthetic Plastic Surgery and American Society of Plastic Surgeons Offer Patient Advisory for those Affected by Fig LipoDissolve Closures
3. FDA Advisory Panel Finds Hologics Adiana(R) Permanent Contraception Approvable
4. Bradmer announces additions to Scientific Advisory Board
5. Antibody Engineering Company f-star Appoints Three Pioneers in Antibody Engineering and Development to its Newly Established Scientific Advisory Board
6. FDA Advisory Committee Recommends Approval of KYNAPID(TM) for Acute Atrial Fibrillation
7. JPMorgans 26th Annual Healthcare Conference Media Advisory
8. FDA Advisory Committee Votes Unanimously to Recommend Approval of Tetrabenazine for Chorea Associated With Huntington Disease
9. Marketing Powerhouse Wendy Banks Joins Frutels Advisory Board
10. MedcomSoft appoints former U.S. presidential health advisor, James Haveman, to health Care advisory board
11. Targeted Genetics Reports on Recombinant DNA Advisory Committee (RAC) Assessment of Its Phase I/II Trial of tgAAC94 for Inflammatory Arthritis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... ... 2016 , ... It is vital for any lab to secure funding, and ... team at Beckman Coulter has designed Kaluza, templates with advanced analytical tools to streamline ... operate in a GLP (Good Laboratory Practice) fashion. , With features designed to simplify ...
(Date:12/7/2016)... ... ... came time to blow out his candles on his 14th birthday, Estefano Reano had only ... team at Joe DiMaggio Children’s Hospital surprised his family with a phone call that made ... , “He was playing at home, when we got the phone call telling us there ...
(Date:12/7/2016)... ... ... One of two inventors from Glen Burnie, Md., has a granddaughter who ... is why the co-inventor and I have designed a new and better way to ... of the patent-pending AV-AIR, a device that serves as an alternative to conventional methods ...
(Date:12/7/2016)... ... December 07, 2016 , ... ... that its fully redesigned website, which launched October 17, 2016, features comprehensive information ... design and easy-to-navigate layout. Visitors and patients can discover the latest clinical dermatology ...
(Date:12/7/2016)... City, CA (PRWEB) , ... December 07, 2016 , ... ... during the holidays and winter seasons. One major study analyzing heart attacks among ... compared to August of a given year. We would all agree of course–no time ...
Breaking Medicine News(10 mins):
(Date:12/7/2016)... PARK , Israel , December 7, 2016 ... today the signing of a memorandum of understanding with Korean company ... between the companies will assist in expediting Kadimastem,s entry into international ... innovative treatment for severe diseases in general and ALS and diabetes ... , , ...
(Date:12/7/2016)... , Dec. 7, 2016 Boehringer Ingelheim ... in patients with unresectable malignant pleural mesothelioma (MPM) ... The data, presented at the 17 th ... Vienna , showed nintedanib plus pemetrexed/cisplatin ... plus pemetrexed/cisplatin, with a significantly improved PFS (9.4 ...
(Date:12/7/2016)... , Dec. 7, 2016  Ionis Pharmaceuticals, Inc. (NASDAQ: ... will present a company overview at the BMO Capital Markets Prescriptions ... New York, NY . A live webcast of ... of the Ionis website.  The replay will be available within 48 ... ...
Breaking Medicine Technology: